Aenitis Technologies — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Aenitis Technologies is a Paris-based medical device company that has developed a disruptive acoustic levitation platform for gentle, contactless bioprocessing. Its technology enables critical cell handling steps like sorting and concentration within a continuous flow system, designed to preserve cell viability and functionality from research to GMP manufacturing. The company operates a Modular Type Package (MTP) business model, providing flexible, scalable solutions and single-use consumables to biopharma partners. With backing from strategic investors and partnerships like the one with Bracco, Aenitis is positioned to address key scalability and efficiency challenges in the advanced therapy manufacturing sector.

OncologyRare DiseasesGenetic Disorders

Technology Platform

Patented acoustic levitation system for contact-free, gentle manipulation of cells in continuous flow. Enables cell sorting, washing, isolation, and concentration. Modular, GMP-ready platform with single-use consumables.

Opportunities

The rapid growth of the cell and gene therapy market creates a pressing need for scalable, gentle, and cost-effective manufacturing solutions.

Aenitis's acoustic platform is uniquely positioned to become a standard tool in this space, especially as therapies move from autologous to allogeneic models requiring larger-scale production.

Partnerships with large biopharma companies and CDMOs could rapidly accelerate adoption and validate the technology across multiple therapy types.

Risk Factors

Primary risks include slower-than-expected adoption of a novel technology in a regulated industry with entrenched processes.

The company faces competition from both conventional methods and other emerging technologies.

Scaling manufacturing for single-use consumables and maintaining quality while meeting potential demand presents an operational execution risk.

Competitive Landscape

Aenitis competes with traditional bioprocessing equipment companies offering centrifuges and filtration systems (e.g., Thermo Fisher, Sartorius), as well as specialized cell sorting companies like Miltenyi Biotec (MACS) and BD (FACS). Its key differentiation is the contact-free, low-shear nature of acoustic manipulation, which claims superior cell viability and functionality preservation. Other companies exploring acoustics for life sciences (e.g., Berkeley Lights, LevitasBio) focus on different applications like single-cell analysis, creating a niche for Aenitis in large-scale bioprocessing.

More companies in Drug Delivery & Formulation →More companies in France →